You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

RET rearrangement

Showing 1 - 25 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Non Small Cell Lung Cancer Trial in Seoul (Vandetanib)

Completed
  • Non Small Cell Lung Cancer
  • Seoul, Korea, Republic of
  • +1 more
Dec 4, 2020

NSCLC, NSCLC Metastatic, NSCLC Recurrent Trial in Worldwide (Alectinib)

Terminated
  • Non-small Cell Lung Cancer
  • +2 more
  • Brussels, Belgium
  • +18 more
Aug 23, 2022

RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Worldwide

Active, not recruiting
  • RET-altered Non Small Cell Lung Cancer
  • +39 more
  • pralsetinib (BLU-667)
  • Phoenix, Arizona
  • +65 more
Nov 10, 2022

NSCLC, Medullary Thyroid Cancer, Colon Cancer Trial in Worldwide (LOXO-292)

Recruiting
  • Non-Small Cell Lung Cancer
  • +3 more
  • Scottsdale, Arizona
  • +84 more
Oct 10, 2022

China With Non-Small-Cell Lung Cancer That is Unable to be

Not yet recruiting
  • Carcinoma, Non-Small-Cell Lung
    • (no location specified)
    May 16, 2023

    Cancer, Cancer Metastatic, NTRK Gene Fusion Overexpression Trial in Worldwide (Data collection and quality of life

    Recruiting
    • Cancer
    • +15 more
    • Data collection and quality of life questionnaire
    • Graz, Austria
    • +40 more
    Jul 27, 2021

    NSCLC Trial in London (MPDL3280A, Vemurafenib, Alectinib)

    Recruiting
    • Non-small Cell Lung Cancer
    • London, United Kingdom
      Univeristy College London Hospital
    Feb 22, 2022

    NSCLC Trial in Worldwide (Osimertinib, Savolitinib, Gefitinib)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Duarte, California
    • +52 more
    Jan 19, 2023

    Nonsmall Cell Lung Cancer Trial in Shanghai (HS-10365 capsules)

    Recruiting
    • Nonsmall Cell Lung Cancer
    • HS-10365 capsules
    • Shanghai, Shanghai, China
      Shanghai Chest Hospital
    Nov 22, 2023

    RET-altered Non Small Cell Lung Cancer, Medullary Thyroid Cancer, RET-altered Papillary Thyroid Cancer Trial in Chang chun

    Not yet recruiting
    • RET-altered Non Small Cell Lung Cancer
    • +3 more
    • Chang chun, Jilin, China
      Jinlin Province Cancer Hosipital
    Dec 21, 2022

    Testing Tumor Tissue and Blood to Help Select Personalized

    Not yet recruiting
    • NSCLC
    • ctDNA, tumor NGS
    • (no location specified)
    Mar 2, 2021

    Locally Advanced Solid Tumors, Metastatic Solid Tumors Trial in Worldwide (Oral repotrectinib (TPX-0005))

    Recruiting
    • Locally Advanced Solid Tumors
    • Metastatic Solid Tumors
    • Oral repotrectinib (TPX-0005)
    • Yuma, Arizona
    • +175 more
    Jan 25, 2023

    NSCLC Trial in Shanghai (SY-5007)

    Recruiting
    • Non-Small Cell Lung Cancer
    • Shanghai, Shanghai, China
      Shanghai Pulmonary Hospital
    Sep 4, 2023

    Patient Journey With Advanced Lung Cancer Positive for ALK

    Recruiting
    • Carcinoma, Non-Small-Cell Lung
      • Fortaleza, Ceará, Brazil
      • +4 more
      Sep 26, 2022

      Advanced Solid Tumor Trial in Los Angeles (EP0031)

      Recruiting
      • Advanced Solid Tumor
      • Los Angeles, California
      • +3 more
      Dec 1, 2022

      Refractory Solid Tumors Trial in Seoul (sunitinib)

      Completed
      • Refractory Solid Tumors
      • Seoul, Korea, Republic of
        Samsung Medical Center
      Jun 13, 2022

      Solid Tumor, Medullary Thyroid Cancer Trial in China (Selpercatinib)

      Active, not recruiting
      Has Results
      • Solid Tumor
      • Medullary Thyroid Cancer
      • Guangzhou, Guangdong, China
      • +12 more
      May 9, 2022

      Hematopoietic and Lymphoid Cell Tumor, Recurrent Ependymoma, Recurrent Ewing Sarcoma Trial in Puerto Rico, United States

      Recruiting
      • Hematopoietic and Lymphoid Cell Neoplasm
      • +37 more
      • Birmingham, Alabama
      • +171 more
      Aug 24, 2022

      MDD Trial in Ames (Resistance Exercise Training)

      Active, not recruiting
      • Major Depressive Disorder
      • Resistance Exercise Training
      • Ames, Iowa
        Iowa State University
      Jan 12, 2023

      NSCLC, Medullary Thyroid Cancer, Solid Tumor Trial in Shanghai, Tianjin (SY-5007)

      Recruiting
      • Non-Small Cell Lung Cancer
      • +2 more
      • Shanghai, Shanghai, China
      • +1 more
      Mar 17, 2022

      Lung Cancer, Nonsmall Cell Trial in Aurora (Crizotinib)

      Completed
      Has Results
      • Lung Cancer, Nonsmall Cell
      • Aurora, Colorado
        University of Colorado Denver
      Jan 19, 2022

      Stroke Trial (Power-focused resistance training)

      Not yet recruiting
      • Stroke
      • Power-focused resistance training
      • (no location specified)
      Apr 18, 2023

      Unresectable Cholangiocarcinoma, Metastatic Cholangiocarcinoma Trial in Worldwide (Pemigatinib, Gemcitabine, Cisplatin)

      Recruiting
      • Unresectable Cholangiocarcinoma
      • Metastatic Cholangiocarcinoma
      • Phoenix, Arizona
      • +212 more
      Nov 15, 2022

      NSCLC, Thyroid Tumors Trial (LOXO-260)

      Temporarily not available
      • Carcinoma, Non-Small-Cell Lung
      • Thyroid Neoplasms
      • (no location specified)
      Sep 20, 2022

      Non-squamous NSCLC Trial in Nanjing (paclitaxel polymeric micelles for injection)

      Not yet recruiting
      • Non-squamous NSCLC
      • paclitaxel polymeric micelles for injection
      • Nanjing, Jiangsu, China
      • +1 more
      Mar 13, 2023